Versant Capital Management »

Phathom Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.2k 197 6.27

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
Carlyle
BlackRock
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Daniel D. Thurber
Catalys Pacific
Jennifer Ranahan
Catalio Capital Management
Geode Capital Management

View all funds holding Phathom Pharmaceuticals